Skip to main content
. 2022 Aug 13;12(12):4365–4377. doi: 10.1016/j.apsb.2022.08.004

Figure 7.

Figure 7

Current status in China of new anticancer drugs approved in the US (A) A cumulative number of new anticancer drugs approved in the U.S. from 2000 to 2020 and of which the number of drugs approved in China as of May 2021 (B) Proportion of drugs in various stages in China as of May 2021 among new anticancer drugs approved in the US between 2000 and 2020. IND, investigational new drug application; NDA, new drug application.